The DOI matches its Crossref record; 259 of the 259 references it cites were found in a registry or an index.
Cell Death and Cell Death Responses in Liver Disease: Mechanisms and Clinical Relevance
Open accessAbstract
Summary Hepatocellular death is present in almost all types of human liver disease and is used as a sensitive parameter for the detection of acute and chronic liver disease of viral, toxic, metabolic, or autoimmune origin. Clinical data and animal models suggest that hepatocyte death is the key trigger of liver disease progression, manifested by the subsequent development of inflammation, fibrosis, cirrhosis, and hepatocellular carcinoma. Modes of hepatocellular death differ substantially between liver diseases. Different modes of cell death such as apoptosis, necrosis, and necroptosis trigger specific cell death responses and promote progression of liver disease through distinct mechanisms. In this review, we first discuss molecular mechanisms by which different modes of cell death, damage-associated molecular patterns, and specific cell death responses contribute to the development of liver disease. We then review the clinical relevance of cell death, focusing on biomarkers; the contribution of cell death to drug-induced, viral, and fatty liver disease and liver cancer; and evidence for cell death pathways as therapeutic targets.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Antoine, D. J., Jenkins, R. E., Dear, J. W., Williams, D. P., McGill, M. R., Sharpe, M. R., Craig, D. G., Simpson, K. J., Jaeschke, H., & Park, B. K. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.12.019 · Cited by 309
RetractedApoptosis: A Basic Biological Phenomenon with Wideranging Implications in Tissue Kinetics
Kerr, J. F. R., Wyllie, A. H., & Currie, A. R. (1972) · British Journal of Cancer · doi:10.1038/bjc.1972.33 · Cited by 15,725
Pattern Recognition Receptors and Inflammation
Takeuchi, O., & Akira, S. (2010) · Cell · doi:10.1016/j.cell.2010.01.022 · Cited by 8,895
Mizgerd, J. P., Kubo, H., Kutkoski, G. J., Bhagwan, S. D., Scharffetter-Kochanek, K., Beaudet, A. L., & Doerschuk, C. M. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.8.1357 · Cited by 7,306
Control of inositol 1,4,5-trisphosphate-induced Ca2+ release by cytosolic Ca2+
Bootman, M. D., Missiaen, L., Parys, J. B., De Smedt, H., & Casteels, R. (1995) · Biochemical Journal · doi:10.1042/bj3060445 · Cited by 5,120
Oxyl radicals, redox-sensitive signalling cascades and antioxidants
Genestra, M. (2007) · Cellular Signalling · doi:10.1016/j.cellsig.2007.04.009 · Cited by 4,930
Danial, N. N., & Korsmeyer, S. J. (2004) · Cell · doi:10.1016/s0092-8674(04)00046-7 · Cited by 4,651
Release of chromatin protein HMGB1 by necrotic cells triggers inflammation
Scaffidi, P., Misteli, T., & Bianchi, M. E. (2002) · Nature · doi:10.1038/nature00858 · Cited by 4,221 · cited 2×
“High-mobility group box 1 (HMGB1) is a non-histone DNA binding protein that is present in virtually all eukaryotic cells.177 HMGB1 is passively released from necrotic cells, and may – following hyperacetylation - also be actively secreted from inflammatory cells.177 Apoptotic cells only release M AN US CR IP T AC CE P…”
The Danger Model: A Renewed Sense of Self
Matzinger, P. (2002) · Science · doi:10.1126/science.1071059 · Cited by 4,205
Autophagy regulates lipid metabolism
Singh, R., Kaushik, S., Wang, Y., Xiang, Y., Novak, I., Komatsu, M., Tanaka, K., Cuervo, A. M., & Czaja, M. J. (2009) · Nature · doi:10.1038/nature07976 · Cited by 3,975
El-Serag, H. B. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1001683 · Cited by 3,529
HMG-1 as a Late Mediator of Endotoxin Lethality in Mice
Wang, H., Bloom, O., Zhang, M., Vishnubhakat, J. M., Ombrellino, M., Che, J., Frazier, A., Yang, H., Ivanova, S., Borovikova, L., et al. (1999) · Science · doi:10.1126/science.285.5425.248 · Cited by 3,385
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
Sanyal, A. J., Chalasani, N., Kowdley, K. V., McCullough, A., Diehl, A. M., Bass, N. M., Neuschwander-Tetri, B. A., Lavine, J. E., Tonascia, J., Unalp, A., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907929 · Cited by 3,327
Yang, Y., Li, S., Yang, Q., Shi, Y., Zheng, M., Liu, Y., Chen, F., Song, G., Xu, H., Wan, T., et al. (2014) · Cellular Physiology and Biochemistry · doi:10.1159/000358696 · Cited by 3,253
Vernon, G., Baranova, A., & Younossi, Z. M. (2011) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2011.04724.x · Cited by 3,074
Sterile inflammation: sensing and reacting to damage
Chen, G. Y., & Nuñez, G. (2010) · Nature Reviews Immunology · doi:10.1038/nri2873 · Cited by 3,051
Two CD95 (APO‐1/Fas) signaling pathways
Scaffidi, C., Fulda, S., Srinivasan, A., Friesen, C., Li, F., Tomaselli, K. J., Debatin, K., Krammer, P. H., & Peter, M. E. (1998) · The EMBO Journal · doi:10.1093/emboj/17.6.1675 · Cited by 3,000
EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection
European Association for the Study of the Liver (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.02.010 · Cited by 2,925
Michalopoulos, G. K., & DeFrances, M. C. (1997) · Science · doi:10.1126/science.276.5309.60 · Cited by 2,828
NF-κB at the crossroads of life and death
Karin, M., & Lin, A. (2002) · Nature Immunology · doi:10.1038/ni0302-221 · Cited by 2,709
Autophagy in Human Health and Disease
Choi, A. M. K., Ryter, S. W., & Levine, B. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1205406 · Cited by 2,583
High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal
Lotze, M. T., & Tracey, K. J. (2005) · Nature Reviews Immunology · doi:10.1038/nri1594 · Cited by 2,487
Cho, Y., Challa, S., Moquin, D., Genga, R., Ray, T. D., Guildford, M., & Chan, F. K.-M. (2009) · Cell · doi:10.1016/j.cell.2009.05.037 · Cited by 2,435 · cited 1×
“assembly of RIP1/RIP3 complexes in the liver, suggesting necroptosis as a component of antiviral responses.(95) RIP3-deficient mice show decreased hepatocyte death after acetaminophen intoxication and chronic ethanol feeding, suggesting an involvement of necroptosis in these diseases.”
NF-κB functions as a tumour promoter in inflammation-associated cancer
Pikarsky, E., Porat, R. M., Stein, I., Abramovitch, R., Amit, S., Kasem, S., Gutkovich-Pyest, E., Urieli-Shoval, S., Galun, E., & Ben-Neriah, Y. (2004) · Nature · doi:10.1038/nature02924 · Cited by 2,430
Özcan, U., Yilmaz, E., Özcan, L., Furuhashi, M., Vaillancourt, E., Smith, R. O., Görgün, C. Z., & Hotamisligil, G. S. (2006) · Science · doi:10.1126/science.1128294 · Cited by 2,413
Baines, C. P., Kaiser, R. A., Purcell, N. H., Blair, N. S., Osinska, H., Hambleton, M. A., Brunskill, E. W., Sayen, M. R., Gottlieb, R. A., Dorn, G. W., et al. (2005) · Nature · doi:10.1038/nature03434 · Cited by 2,280
Receptor Interacting Protein Kinase-3 Determines Cellular Necrotic Response to TNF-α
He, S., Wang, L., Miao, L., Wang, T., Du, F., Zhao, L., & Wang, X. (2009) · Cell · doi:10.1016/j.cell.2009.05.021 · Cited by 2,214
Human Fatty Liver Disease: Old Questions and New Insights
Cohen, J. C., Horton, J. D., & Hobbs, H. H. (2011) · Science · doi:10.1126/science.1204265 · Cited by 2,089 · cited 6×
“steatosis by presence of hepatocyte death and subsequent cell death responses - visible as hepatocyte ballooning, an inflammatory infiltrate, and/or collagen deposition – and promotes the develepment of fibrosis, cirrhosis and HCC.(201) Despite clinical trials on multiple molecular targets in NASH patients,(202) no ef…”
InfluentialAlcoholic Liver Disease: Pathogenesis and New Therapeutic Targets
Gao, B., & Bataller, R. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.09.002 · Cited by 1,963 · cited 2×
“Cytotoxic effects of alcohol are at least in part caused by its metabolite acetaldehyde, which causes excess ROS production leading to lipid peroxidation, mitochondrial damage and cell death.(221,225) Accordingly, treatment with antioxidants ameliorates experimental alcoholic liver injury.”
TLR4 enhances TGF-β signaling and hepatic fibrosis
Seki, E., De Minicis, S., Österreicher, C. H., Kluwe, J., Osawa, Y., Brenner, D. A., & Schwabe, R. F. (2007) · Nature Medicine · doi:10.1038/nm1663 · Cited by 1,942
Self-citationHoller, N., Zaru, R., Micheau, O., Thome, M., Attinger, A., Valitutti, S., Bodmer, J.-L., Schneider, P., Seed, B., & Tschopp, J. (2000) · Nature Immunology · doi:10.1038/82732 · Cited by 1,938
RIP3, an Energy Metabolism Regulator That Switches TNF-Induced Cell Death from Apoptosis to Necrosis
Zhang, D.-W., Shao, J., Lin, J., Zhang, N., Lu, B.-J., Lin, S.-C., Dong, M.-Q., & Han, J. (2009) · Science · doi:10.1126/science.1172308 · Cited by 1,931
Chang, M.-H., Chen, C.-J., Lai, M.-S., Hsu, H.-M., Wu, T.-C., Kong, M.-S., Liang, D.-C., Shau, W.-Y., & Chen, D.-S. (1997) · New England Journal of Medicine · doi:10.1056/nejm199706263362602 · Cited by 1,883
Lethal effect of the anti-Fas antibody in mice
Ogasawara, J., Watanabe-Fukunaga, R., Adachi, M., Matsuzawa, A., Kasugai, T., Kitamura, Y., Itoh, N., Suda, T., & Nagata, S. (1993) · Nature · doi:10.1038/364806a0 · Cited by 1,881
A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis
Belfort, R., Harrison, S. A., Brown, K., Darland, C., Finch, J., Hardies, J., Balas, B., Gastaldelli, A., Tio, F., Pulcini, J., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa060326 · Cited by 1,827
Chalasani, N., Younossi, Z., Lavine, J. E., Diehl, A. M., Brunt, E. M., Cusi, K., Charlton, M., & Sanyal, A. J. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.04.001 · Cited by 1,775
Regulated necrosis: the expanding network of non-apoptotic cell death pathways
Berghe, T. V., Linkermann, A., Jouan-Lanhouet, S., Walczak, H., & Vandenabeele, P. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3737 · Cited by 1,735
Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance
Elliott, M. R., Chekeni, F. B., Trampont, P. C., Lazarowski, E. R., Kadl, A., Walk, S. F., Park, D., Woodson, R. I., Ostankovich, M., Sharma, P., et al. (2009) · Nature · doi:10.1038/nature08296 · Cited by 1,654
Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair
Duffield, J. S., Forbes, S. J., Constandinou, C. M., Clay, S., Partolina, M., Vuthoori, S., Wu, S., Lang, R., & Iredale, J. P. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200522675 · Cited by 1,649
Nakagawa, T., Shimizu, S., Watanabe, T., Yamaguchi, O., Otsu, K., Yamagata, H., Inohara, H., Kubo, T., & Tsujimoto, Y. (2005) · Nature · doi:10.1038/nature03317 · Cited by 1,635
Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis
Angulo, P., Keach, J. C., Batts, K. P., & Lindor, K. D. (1999) · Hepatology · doi:10.1002/hep.510300604 · Cited by 1,610
Wang, H., Sun, L., Su, L., Rizo, J., Liu, L., Wang, L.-F., Wang, F.-S., & Wang, X. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.03.003 · Cited by 1,563
Predicting Cirrhosis Risk Based on the Level of Circulating Hepatitis B Viral Load
Iloeje, U. H., Yang, H., Su, J., Jen, C., You, S., & Chen, C. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.11.016 · Cited by 1,528
Guichard, C., Amaddeo, G., Imbeaud, S., Ladeiro, Y., Pelletier, L., Maad, I. B., Calderaro, J., Bioulac-Sage, P., Letexier, M., Degos, F., et al. (2012) · Nature Genetics · doi:10.1038/ng.2256 · Cited by 1,453
Mederacke, I., Hsu, C. C., Troeger, J. S., Huebener, P., Mu, X., Dapito, D. H., Pradere, J.-P., & Schwabe, R. F. (2013) · Nature Communications · doi:10.1038/ncomms3823 · Cited by 1,443
Self-citationNecroptosis: The Release of Damage-Associated Molecular Patterns and Its Physiological Relevance
Kaczmarek, A., Vandenabeele, P., & Krysko, D. V. (2013) · Immunity · doi:10.1016/j.immuni.2013.02.003 · Cited by 1,411
Lemasters, J. J., Nieminen, A.-L., Qian, T., Trost, L. C., Elmore, S. P., Nishimura, Y., Crowe, R. A., Cascio, W. E., Bradham, C. A., Brenner, D. A., et al. (1998) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/s0005-2728(98)00112-1 · Cited by 1,387
Mitochondria in Apoptosis: Bcl-2 Family Members and Mitochondrial Dynamics
Martinou, J.-C., & Youle, R. J. (2011) · Developmental Cell · doi:10.1016/j.devcel.2011.06.017 · Cited by 1,368
Promotion of Hepatocellular Carcinoma by the Intestinal Microbiota and TLR4
Dapito, D. H., Mencin, A., Gwak, G.-Y., Pradere, J.-P., Jang, M.-K., Mederacke, I., Caviglia, J. M., Khiabanian, H., Adeyemi, A., Bataller, R., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.007 · Cited by 1,346
Self-citationNF-κB in the liver—linking injury, fibrosis and hepatocellular carcinoma
Luedde, T., & Schwabe, R. F. (2011) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2010.213 · Cited by 1,345
Self-citationPlasma membrane translocation of trimerized MLKL protein is required for TNF-induced necroptosis
Cai, Z., Jitkaew, S., Zhao, J., Chiang, H.-C., Choksi, S., Liu, J., Ward, Y., Wu, L.-G., & Liu, Z.-G. (2014) · Nature Cell Biology · doi:10.1038/ncb2883 · Cited by 1,322
TUMOR NECROSIS FACTOR RECEPTOR AND Fas SIGNALING MECHANISMS
Wallach, D., Varfolomeev, E. E., Malinin, N. L., Goltsev, Y. V., Kovalenko, A. V., & Boldin, M. P. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.331 · Cited by 1,312
Protease activation during apoptosis: Death by a thousand cuts?
Martin, S. J., & Green, D. R. (1995) · Cell · doi:10.1016/0092-8674(95)90422-0 · Cited by 1,309
Musso, G., Gambino, R., Cassader, M., & Pagano, G. (2011) · Annals of Medicine · doi:10.3109/07853890.2010.518623 · Cited by 1,293
Intravascular Danger Signals Guide Neutrophils to Sites of Sterile Inflammation
McDonald, B., Pittman, K., Menezes, G. B., Hirota, S. A., Slaba, I., Waterhouse, C. C. M., Beck, P. L., Muruve, D. A., & Kubes, P. (2010) · Science · doi:10.1126/science.1195491 · Cited by 1,210
Maeda, S., Kamata, H., Luo, J.-L., Leffert, H., & Karin, M. (2005) · Cell · doi:10.1016/j.cell.2005.04.014 · Cited by 1,164
Circulating microRNAs, potential biomarkers for drug-induced liver injury
Wang, K., Zhang, S., Marzolf, B., Troisch, P., Brightman, A., Hu, Z., Hood, L. E., & Galas, D. J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813371106 · Cited by 1,149
The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion
Tsung, A., Sahai, R., Tanaka, H., Nakao, A., Fink, M. P., Lotze, M. T., Yang, H., Li, J., Tracey, K. J., Geller, D. A., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20042614 · Cited by 1,113
Linkermann, A., & Green, D. R. (2014) · New England Journal of Medicine · doi:10.1056/nejmra1310050 · Cited by 1,103
Efficacy of Oral N-Acetylcysteine in the Treatment of Acetaminophen Overdose
Smilkstein, M. J., Knapp, G. L., Kulig, K. W., & Rumack, B. H. (1988) · New England Journal of Medicine · doi:10.1056/nejm198812153192401 · Cited by 1,102
Lavine, J. E. (2011) · JAMA · doi:10.1001/jama.2011.520 · Cited by 1,101
Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis
Feldstein, A. E., Canbay, A., Angulo, P., Taniai, M., Burgart, L. J., Lindor, K. D., & Gores, G. J. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00907-7 · Cited by 1,085 · cited 1×
“In ALD, there is evidence for both apoptosis and necrosis.(42,44,224) Cytotoxic effects of alcohol are at least in part caused by its metabolite acetaldehyde, which causes excess ROS production leading to lipid peroxidation, mitochondrial damage and cell death.”
Iredale, J. P., Benyon, R. C., Pickering, J., McCullen, M., Northrop, M., Pawley, S., Hovell, C., & Arthur, M. J. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1018 · Cited by 1,075
RIP3 mediates the embryonic lethality of caspase-8-deficient mice
Kaiser, W. J., Upton, J. W., Long, A. B., Livingston-Rosanoff, D., Daley-Bauer, L. P., Hakem, R., Caspary, T., & Mocarski, E. S. (2011) · Nature · doi:10.1038/nature09857 · Cited by 1,057
Michelotti, G. A., Machado, M. V., & Diehl, A. M. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.183 · Cited by 974
The Fas Signaling Pathway: More Than a Paradigm
Wajant, H. (2002) · Science · doi:10.1126/science.1071553 · Cited by 957
Wang, Z., Jiang, H., Chen, S., Du, F., & Wang, X. (2012) · Cell · doi:10.1016/j.cell.2011.11.030 · Cited by 949
Mudaliar, S., Henry, R. R., Sanyal, A. J., Morrow, L., Marschall, H., Kipnes, M., Adorini, L., Sciacca, C. I., Clopton, P., Castelloe, E., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.05.042 · Cited by 931 · cited 1×
“reported improved insulin sensitivity, weight loss, ALT, GGT and liver fibrosis markers in patients with type II diabetes and NASH treated with the FXR receptor agonist obeticholic acid.(220) However, some effects such as improved ALT levels and fibrosis markers were only observed at the lower obeticholic”
Cusi, K. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.02.003 · Cited by 911
Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis
Roderburg, C., Urban, G.-W., Bettermann, K., Vucur, M., Zimmermann, H., Schmidt, S., Janssen, J., Koppe, C., Knolle, P., Castoldi, M., et al. (2011) · Hepatology · doi:10.1002/hep.23922 · Cited by 803
Self-citationAkriviadis, E., Botla, R., Briggs, W., Han, S., Reynolds, T., & Shakil, O. (2000) · Gastroenterology · doi:10.1053/gast.2000.20189 · Cited by 800
Pathogenic mechanisms in HBV- and HCV-associated hepatocellular carcinoma
Arzumanyan, A., Reis, H. M. G. P. V., & Feitelson, M. A. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3449 · Cited by 800
Heo, J., Reid, T., Ruo, L., Breitbach, C. J., Rose, S., Bloomston, M., Cho, M., Lim, H. Y., Chung, H. C., Kim, C. W., et al. (2013) · Nature Medicine · doi:10.1038/nm.3089 · Cited by 779
Chen, X., Li, W., Ren, J., Huang, D., He, W.-T., Song, Y., Yang, C., Li, W., Zheng, X., Chen, P., et al. (2014) · Cell Research · doi:10.1038/cr.2013.171 · Cited by 779
Louvet, A., Naveau, S., Abdelnour, M., Ramond, M.-J., Diaz, E., Fartoux, L., Dharancy, S., Texier, F., Hollebecque, A., Serfaty, L., et al. (2007) · Hepatology · doi:10.1002/hep.21607 · Cited by 733
Role of the Microenvironment in the Pathogenesis and Treatment of Hepatocellular Carcinoma
Hernandez–Gea, V., Toffanin, S., Friedman, S. L., & Llovet, J. M. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.01.002 · Cited by 722
Inhibition of JNK activation through NF-κB target genes
Tang, G., Minemoto, Y., Dibling, B., Purcell, N. H., Li, Z., Karin, M., & Lin, A. (2001) · Nature · doi:10.1038/35104568 · Cited by 721
Festjens, N., Vanden Berghe, T., & Vandenabeele, P. (2006) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2006.06.014 · Cited by 710
Antibiotics prevent liver injury in rats following long-term exposure to ethanol
Adachi, Y., Moore, L. E., Bradford, B. U., Gao, W., & Thurman, R. G. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90027-6 · Cited by 692
Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage.
Galle, P. R., Hofmann, W. J., Walczak, H., Schaller, H., Otto, G., Stremmel, W., Krammer, P. H., & Runkel, L. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.5.1223 · Cited by 692
Apoptosis and Necrosis in the Liver: A Tale of Two Deaths?
Malhi, H., Gores, G. J., & Lemasters, J. J. (2006) · Hepatology · doi:10.1002/hep.21062 · Cited by 691
Mechanisms of Liver Injury. I. TNF-α-induced liver injury: role of IKK, JNK, and ROS pathways
Schwabe, R. F., & Brenner, D. A. (2006) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00422.2005 · Cited by 685
Self-citationSterile inflammation in the liver
Kubes, P., & Mehal, W. Z. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.09.008 · Cited by 666 · cited 6×
“Alcoholic steatohepatitis (ASH) is the severe form of ALD, and may progress to fibrosis, cirrhosis and HCC.132 Similar to NASH, ASH is characterized by hepatic steatosis, cell injury and inflammation.63 In ALD, there is evidence for both apoptosis and necrosis.42,44,224 Cytotoxic effects of alcohol are at least in par…”
InfluentialMitochondrial calcium and the permeability transition in cell death
Lemasters, J. J., Theruvath, T. P., Zhong, Z., & Nieminen, A.-L. (2009) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2009.06.009 · Cited by 654
Lotze, M. T., Zeh, H. J., Rubartelli, A., Sparvero, L. J., Amoscato, A. A., Washburn, N. R., DeVera, M. E., Liang, X., Tör, M., & Billiar, T. (2007) · Immunological Reviews · doi:10.1111/j.1600-065x.2007.00579.x · Cited by 641
Pradere, J.-P., Kluwe, J., De Minicis, S., Jiao, J.-J., Gwak, G.-Y., Dapito, D. H., Jang, M.-K., Guenther, N. D., Mederacke, I., Friedman, R., et al. (2013) · Hepatology · doi:10.1002/hep.26429 · Cited by 613
Self-citationGlycyrrhizin Binds to High-Mobility Group Box 1 Protein and Inhibits Its Cytokine Activities
Mollica, L., De Marchis, F., Spitaleri, A., Dallacosta, C., Pennacchini, D., Zamai, M., Agresti, A., Trisciuoglio, L., Musco, G., & Bianchi, M. E. (2007) · Chemistry & Biology · doi:10.1016/j.chembiol.2007.03.007 · Cited by 612
Acetaminophen-induced hepatotoxicity in mice is dependent on Tlr9 and the Nalp3 inflammasome
Imaeda, A. B., Watanabe, A., Sohail, M. A., Mahmood, S., Mohamadnejad, M., Sutterwala, F. S., Flavell, R. A., & Mehal, W. Z. (2009) · Journal of Clinical Investigation · doi:10.1172/jci35958 · Cited by 607
Lee, W. M., Hynan, L. S., Rossaro, L., Fontana, R. J., Stravitz, R. T., Larson, A. M., Davern, T. J., Murray, N. G., McCashland, T., Reisch, J. S., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.06.006 · Cited by 607
Hyeon, C. K., Chung, M. N., Sun, H. J., Kwang, H. H., Kyu Oh, D., & Suh, I. (2004) · BMJ · doi:10.1136/bmj.38050.593634.63 · Cited by 600
Deletion of NEMO/IKKγ in Liver Parenchymal Cells Causes Steatohepatitis and Hepatocellular Carcinoma
Luedde, T., Beraza, N., Kotsikoris, V., van Loo, G., Nenci, A., De Vos, R., Roskams, T., Trautwein, C., & Pasparakis, M. (2007) · Cancer Cell · doi:10.1016/j.ccr.2006.12.016 · Cited by 597
Self-citationEvolving therapies for liver fibrosis
Schuppan, D., & Kim, Y. O. (2013) · Journal of Clinical Investigation · doi:10.1172/jci66028 · Cited by 595
FADD prevents RIP3-mediated epithelial cell necrosis and chronic intestinal inflammation
Welz, P.-S., Wullaert, A., Vlantis, K., Kondylis, V., Fernández-Majada, V., Ermolaeva, M., Kirsch, P., Sterner-Kock, A., van Loo, G., & Pasparakis, M. (2011) · Nature · doi:10.1038/nature10273 · Cited by 594
Tseng, T., Liu, C., Yang, H., Su, T., Wang, C., Chen, C., Kuo, S. F., Liu, C., Chen, P., Chen, D., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.02.007 · Cited by 574
The de ritis ratio: the test of time.
Botros, M., & Sikaris, K. A. (2013) · Europe PMC (PubMed Central) · Cited by 573
Beginnings of a Good Apoptotic Meal: The Find-Me and Eat-Me Signaling Pathways
Ravichandran, K. S. (2011) · Immunity · doi:10.1016/j.immuni.2011.09.004 · Cited by 559
Two independent pathways of regulated necrosis mediate ischemia–reperfusion injury
Linkermann, A., Bräsen, J. H., Darding, M., Jin, M. K., Sanz, A. B., Heller, J.-O., De Zen, F., Weinlich, R., Ortiz, A., Walczak, H., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1305538110 · Cited by 554
Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis
Argo, C. K., Northup, P. G., Al-Osaimi, A. M. S., & Caldwell, S. H. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.03.019 · Cited by 552
Newton, K., Sun, X., & Dixit, V. M. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.4.1464-1469.2004 · Cited by 551
Toxic bile salts induce rodent hepatocyte apoptosis via direct activation of Fas
Faubion, W. A., Guicciardi, M. E., Miyoshi, H., Bronk, S. F., Roberts, P. J., Svingen, P. A., Kaufmann, S. H., & Gores, G. J. (1999) · Journal of Clinical Investigation · doi:10.1172/jci4765 · Cited by 536
Hanawa, N., Shinohara, M., Saberi, B., Gaarde, W. A., Han, D., & Kaplowitz, N. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m708916200 · Cited by 527
Self-citationWalker, N. I., HARMON, B. V., Gobe, G. C., & Kerr, J. F. R. (1988) · PubMed · Cited by 527
New Hepatitis C Therapies: The Toolbox, Strategies, and Challenges
Pawlotsky, J. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.03.003 · Cited by 518
Autophagy Reduces Acute Ethanol-Induced Hepatotoxicity and Steatosis in Mice
Ding, W., Li, M., Chen, X., Ni, H., Lin, C., Gao, W., Lu, B., Stolz, D. B., Clemens, D. L., & Yin, X. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.07.041 · Cited by 515
Interleukin-33-Dependent Innate Lymphoid Cells Mediate Hepatic Fibrosis
Mchedlidze, T., Waldner, M., Zopf, S., Walker, J., Rankin, A. L., Schuchmann, M., Voehringer, D., McKenzie, A. N. J., Neurath, M. F., Pflanz, S., et al. (2013) · Immunity · doi:10.1016/j.immuni.2013.07.018 · Cited by 502
Kon, K., Kim, J.-S., Jaeschke, H., & Lemasters, J. J. (2004) · Hepatology · doi:10.1002/hep.20437 · Cited by 494
NADPH oxidase–derived free radicals are key oxidants in alcohol-induced liver disease
Kono, H., Rusyn, I., Yin, M., Gäbele, E., Yamashina, S., Dikalova, A., Kadiiska, M. B., Connor, H. D., Mason, R. P., Segal, B. H., et al. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9020 · Cited by 493
Leist, M., Gantner, F., Bohlinger, I., Germann, P. G., Tiegs, G., & Wendel, A. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.153.4.1778 · Cited by 492
Toll–Like Receptor 4 Is Involved in the Mechanism of Early Alcohol–Induced Liver Injury in Mice
Uesugi, T., Froh, M., Arteel, G. E., Bradford, B. U., & Thurman, R. G. (2001) · Hepatology · doi:10.1053/jhep.2001.25350 · Cited by 488
Keays, R., Harrison, P. M., Wendon, J. A., Forbes, A., Gove, C., Alexander, G. J., & Williams, R. (1991) · BMJ · doi:10.1136/bmj.303.6809.1026 · Cited by 488
Mathurin, P., Hollebecque, A., Arnalsteen, L., Buob, D., Leteurtre, E., Caiazzo, R., Pigeyre, M., Verkindt, H., Dharancy, S., Louvet, A., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.04.052 · Cited by 483
C-Jun N-terminal kinase plays a major role in murine acetaminophen hepatotoxicity
Gunawan, B. K., Liu, Z., Han, D., Hanawa, N., Gaarde, W. A., & Kaplowitz, N. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.03.045 · Cited by 471
Self-citationKupffer Cell Engulfment of Apoptotic Bodies Stimulates Death Ligand and Cytokine Expression
Canbay, A., Feldstein, A. E., Higuchi, H., Werneburg, N., Grambihler, A., Bronk, S. F., & Gores, G. J. (2003) · Hepatology · doi:10.1053/jhep.2003.50472 · Cited by 470
Pathogenesis of chronic viral hepatitis: differential roles of T cells and NK cells
Rehermann, B. (2013) · Nature Medicine · doi:10.1038/nm.3251 · Cited by 468
Acetylcysteine for Acetaminophen Poisoning
Heard, K. J. (2008) · New England Journal of Medicine · doi:10.1056/nejmct0708278 · Cited by 467
Mlkl knockout mice demonstrate the indispensable role of Mlkl in necroptosis
Wu, J., Huang, Z., Ren, J., Zhang, Z., He, P., Li, Y., Ma, J., Chen, W., Zhang, Y., Zhou, X., et al. (2013) · Cell Research · doi:10.1038/cr.2013.91 · Cited by 462
Tomita, K., Tamiya, G., Ando, S., Ohsumi, K., Chiyo, T., Mizutani, A., Kitamura, N., Toda, K., Kaneko, T., Horie, Y., et al. (2006) · Gut · doi:10.1136/gut.2005.071118 · Cited by 438
Functions of autophagy in normal and diseased liver
Czaja, M. J., Ding, W.-X., Donohue, T. M., Friedman, S. L., Kim, J.-S., Komatsu, M., Lemasters, J. J., Lemoine, A., Lin, J. D., Ou, J.-H. J., et al. (2013) · Autophagy · doi:10.4161/auto.25063 · Cited by 436
Activation of Autophagy Protects Against Acetaminophen–Induced Hepatotoxicity
Ni, H., Bockus, A., Boggess, N., Jaeschke, H., & Ding, W. (2012) · Hepatology · doi:10.1002/hep.24690 · Cited by 430
Antoine, D. J., Dear, J. W., Lewis, P. S., Platt, V., Coyle, J., Masson, M., Thanacoody, R. H., Gray, A. J., Webb, D. J., Moggs, J. G., et al. (2013) · Hepatology · doi:10.1002/hep.26294 · Cited by 427
Apoptotic Body Engulfment by a Human Stellate Cell Line Is Profibrogenic
Canbay, A., Taimr, P., Torok, N., Higuchi, H., Friedman, S., & Gores, G. J. (2003) · Laboratory Investigation · doi:10.1097/01.lab.0000069036.63405.5c · Cited by 417
Glucocorticoids plus N-Acetylcysteine in Severe Alcoholic Hepatitis
Nguyen-Khac, E., Thevenot, T., Piquet, M.-A., Benferhat, S., Goria, O., Chatelain, D., Tramier, B., Dewaele, F., Ghrib, S., Rudler, M., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1101214 · Cited by 410
Progression of fibrosis in chronic hepatitis C
Ghany, M. G., Kleiner, D. E., Alter, H., Doo, E., Khokar, F., Promrat, K., Herion, D., Park, Y., Liang, T. J., & Hoofnagle, J. H. (2003) · Gastroenterology · doi:10.1053/gast.2003.50018 · Cited by 403
Signaling cell death from the endoplasmic reticulum stress response
Shore, G. C., Papa, F. R., & Oakes, S. A. (2011) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2010.11.003 · Cited by 402
Caspase‐activation pathways in apoptosis and immunity
Creagh, E. M., Conroy, H., & Martin, S. J. (2003) · Immunological Reviews · doi:10.1034/j.1600-065x.2003.00048.x · Cited by 382
Gane, E. J., Weilert, F., Orr, D. W., Keogh, G. F., Gibson, M., Lockhart, M. M., Frampton, C. M., Taylor, K. M., Smith, R. A. J., & Murphy, M. P. (2010) · Liver International · doi:10.1111/j.1478-3231.2010.02250.x · Cited by 379
Prognostic determinants for chronic hepatitis B in Asians: therapeutic implications
Yuen, M.-F., Yuan, H.-J., Wong, D. K.-H., Yuen, J. C.-H., Wong, W.-M., Chan, A. O.-O., Wong, B. C.-Y., Lai, K.-C., & Lai, C.-L. (2005) · Gut · doi:10.1136/gut.2005.065136 · Cited by 375
Targeted mutation in the Fas gene causes hyperplasia in peripheral lymphoid organs and liver
Adachi, M., Suematsu, S., Kondo, T., Ogasawara, J., Tanaka, T., Yoshida, N., & Nagata, S. (1995) · Nature Genetics · doi:10.1038/ng1195-294 · Cited by 374
Programmed necrosis: backup to and competitor with apoptosis in the immune system
Han, J., Zhong, C.-Q., & Zhang, D.-W. (2011) · Nature Immunology · doi:10.1038/ni.2159 · Cited by 367
Autoimmune Hepatitis: Effect of Symptoms and Cirrhosis on Natural History and Outcome *
Feld, J. J., Dinh, H., Arenovich, T., Marcus, V. A., Wanless, I. R., & Heathcote, J. E. (2005) · Hepatology · doi:10.1002/hep.20732 · Cited by 367
Ni, Y.-H., Chang, M.-H., Huang, L.-M., Chen, H.-L., Hsu, H.-Y., Chiu, T.-Y., Tsai, K.-S., & Chen, D.-S. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-135-9-200111060-00009 · Cited by 365
Gude, D. R., Alvarez, S. E., Paugh, S. W., Mitra, P., Yu, J., Griffiths, R., Barbour, S. E., Milstien, S., & Spiegel, S. (2008) · The FASEB Journal · doi:10.1096/fj.08-107169 · Cited by 364
Cell death and infection: A double-edged sword for host and pathogen survival
Ashida, H., Mimuro, H., Ogawa, M., Kobayashi, T., Sanada, T., Kim, M., & Sasakawa, C. (2011) · Journal of Cell Biology · doi:10.1083/jcb.201108081 · Cited by 361
Pentoxifylline improves nonalcoholic steatohepatitis: A randomized placebo-controlled trial
Zein, C. O., Yerian, L. M., Gogate, P., Lopez, R., Kirwan, J. P., Feldstein, A. E., & McCullough, A. J. (2011) · Hepatology · doi:10.1002/hep.24544 · Cited by 356
Ruhl, C. E., & Everhart, J. E. (2009) · Gastroenterology · doi:10.1053/j.gastro.2008.10.052 · Cited by 352
Mecanismos de lesión hepatocelular
Muntané, J., González, R., Ranchal, I., Collado, J. A., López-Sánchez, L. M., Herencia, C., Rodríguez-Ariza, A., Muñoz-Castañeda, J. R., & de la Mata, M. (2007) · Revista Española de Enfermedades Digestivas · doi:10.4321/s1130-01082007000700007 · Cited by 349
Wiese, M., Berr, F., Lafrenz, M., Porst, H., & Oesen, U. (2000) · Hepatology · doi:10.1053/jhep.2000.8169 · Cited by 349
Boetticher, N. C., Peine, C. J., Kwo, P., Abrams, G. A., Patel, T., Aqel, B., Boardman, L., Gores, G. J., Harmsen, W. S., McClain, C. J., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.08.057 · Cited by 340
Muppidi, J. R., Tschopp, J., & Siegel, R. M. (2004) · Immunity · doi:10.1016/j.immuni.2004.10.001 · Cited by 338
Gao, W., Bentley, R. C., Madden, J. F., & Clavien, P.-A. (1998) · Hepatology · doi:10.1002/hep.510270626 · Cited by 327
The liver as a site of T-cell apoptosis: graveyard, or killing field?
Crispe, I. N., Dao, T., Klugewitz, K., Mehal, W. Z., & Metz, D. P. (2000) · Immunological Reviews · doi:10.1034/j.1600-0528.2002.017412.x · Cited by 321
Involvement of mitochondrial permeability transition in acetaminophen-induced liver injury in mice
Masubuchi, Y., Suda, C., & Horie, T. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2004.09.015 · Cited by 317
Luedde, M., Lutz, M., Carter, N., Sosna, J., Jacoby, C., Vucur, M., Gautheron, J., Roderburg, C., Borg, N., Reisinger, F., et al. (2014) · Cardiovascular Research · doi:10.1093/cvr/cvu146 · Cited by 315
Self-citationMedical therapies for hepatocellular carcinoma: a critical view of the evidence
Villanueva, A., Hernandez-Gea, V., & Llovet, J. M. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2012.199 · Cited by 314 · cited 1×
“The only approved drug for treatment of HCC, sorafenib, affects HCC proliferation and angiogenesis but not cell death.(237) Besides ablative strategies that induce HCC death with low”
A positive feedback loop between RIP3 and JNK controls non‐alcoholic steatohepatitis
Gautheron, J., Vucur, M., Reisinger, F., Cardenas, D. V., Roderburg, C., Koppe, C., Kreggenwinkel, K., Schneider, A. T., Bartneck, M., Neumann, U. P., et al. (2014) · EMBO Molecular Medicine · doi:10.15252/emmm.201403856 · Cited by 314
Self-citationAbsence of receptor interacting protein kinase 3 prevents ethanol-induced liver injury
Roychowdhury, S., McMullen, M. R., Pisano, S. G., Liu, X., & Nagy, L. E. (2013) · Hepatology · doi:10.1002/hep.26200 · Cited by 304 · cited 3×
“RIP3-deficient mice show decreased hepatocyte death after acetaminophen intoxication and chronic ethanol feeding, suggesting an involvement of necroptosis in these diseases.(40,41) Although inhibition of necroptosis by either RIP3 deficiency, RIP1 blockade by necrostatin-1 or MLKL deficiency all reduce cell death at e…”
Serum aminotransferase concentration as evidence of hepatocellular damage
Kew, M. C. (2000) · The Lancet · doi:10.1016/s0140-6736(99)00219-6 · Cited by 300
Bonnet, M. C., Preukschat, D., Welz, P.-S., van Loo, G., Ermolaeva, M. A., Bloch, W., Haase, I., & Pasparakis, M. (2011) · Immunity · doi:10.1016/j.immuni.2011.08.014 · Cited by 295
Zhan, S.-S., Jiang, J. X., Wu, J., Halsted, C., Friedman, S. L., Zern, M. A., & Torok, N. J. (2006) · Hepatology · doi:10.1002/hep.21093 · Cited by 284
Alcoholic liver disease: pathogenesis and new targets for therapy
Altamirano, J., & Bataller, R. (2011) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2011.134 · Cited by 284
Saturated Fatty Acids Induce c-Src Clustering within Membrane Subdomains, Leading to JNK Activation
Holzer, R. G., Park, E.-J., Li, N., Tran, H., Chen, M., Choi, C., Solinas, G., & Karin, M. (2011) · Cell · doi:10.1016/j.cell.2011.08.034 · Cited by 284
Disruption of TAK1 in hepatocytes causes hepatic injury, inflammation, fibrosis, and carcinogenesis
Inokuchi, S., Aoyama, T., Miura, K., Österreicher, C. H., Kodama, Y., Miyai, K., Akira, S., Brenner, D. A., & Seki, E. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909781107 · Cited by 279
Hepatocyte apoptosis is a pathologic feature of human alcoholic hepatitis
Natori, S., Rust, C., Stadheim, L. M., Srinivasan, A., Burgart, L. J., & Gores, G. J. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(00)00089-1 · Cited by 273
Chen, C., Lee, W., Yang, H., Chang, H., Jen, C., Iloeje, U. H., Su, J., Hsiao, C. K., Wang, L., You, S., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.06.036 · Cited by 268
Ramachandran, A., McGill, M. R., Xie, Y., Ni, H.-M., Ding, W.-X., & Jaeschke, H. (2013) · Hepatology · doi:10.1002/hep.26547 · Cited by 257
Pan-caspase inhibitor VX-166 reduces fibrosis in an animal model of nonalcoholic steatohepatitis #
Witek, R. P., Stone, C. W., Karaca, G. F., Syn, W.-K., Pereira, T. A., Agboola, K. M., Omenetti, A., Jung, Y., Teaberry, V., Choi, S. S., et al. (2009) · Hepatology · doi:10.1002/hep.23167 · Cited by 253
C–Jun–N–Terminal Kinase Drives Cyclin D1 Expression and Proliferation During Liver Regeneration
Schwabe, R. F., Bradham, C. A., Uehara, T., Hatano, E., Bennett, B. L., Schoonhoven, R., & Brenner, D. A. (2003) · Hepatology · doi:10.1053/jhep.2003.50135 · Cited by 251
Self-citationExpression and Role of Bcl–Xl in Human Hepatocellular Carcinomas
Takehara, T., Liu, X., Fujimoto, J., Friedman, S. L., & Takahashi, H. (2001) · Hepatology · doi:10.1053/jhep.2001.25387 · Cited by 246
Mcl-1 overexpression in hepatocellular carcinoma: A potential target for antisense therapy
Sieghart, W., Losert, D., Strommer, S., Cejka, D., Schmid, K., Rasoul-Rockenschaub, S., Bodingbauer, M., Crevenna, R., Monia, B. P., Peck-Radosavljevic, M., et al. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2005.09.010 · Cited by 244
Bantel, H., Lügering, A., Heidemann, J., Volkmann, X., Poremba, C., Strassburg, C. P., Manns, M. P., & Schulze-Osthoff, K. (2004) · Hepatology · doi:10.1002/hep.20411 · Cited by 242
Long-term outcome of chronic hepatitis B in Caucasian patients: mortality after 25 years
Fattovich, G., Olivari, N., Pasino, M., D’Onofrio, M., Martone, E., & Donato, F. (2008) · Gut · doi:10.1136/gut.2007.128496 · Cited by 241
Cyclophilin D as a Drug Target
Waldmeier, P., Zimmermann, K., Qian, T., Tintelnot-Blomley, M., & Lemasters, J. (2003) · Current Medicinal Chemistry · doi:10.2174/0929867033457160 · Cited by 234
Takehara, T., Tatsumi, T., Suzuki, T., Rucker, E. B., Hennighausen, L., Jinushi, M., Miyagi, T., Kanazawa, Y., & Hayashi, N. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.07.019 · Cited by 225
Fas/CD95-Induced Chemokines Can Serve as “Find-Me” Signals for Apoptotic Cells
Cullen, S. P., Henry, C. M., Kearney, C. J., Logue, S. E., Feoktistova, M., Tynan, G. A., Lavelle, E. C., Leverkus, M., & Martin, S. J. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.01.025 · Cited by 222
Innate and adaptive immune responses to cell death
Rock, K. L., Lai, J., & Kono, H. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01040.x · Cited by 221
Biomarkers of liver cell death
Eguchi, A., Wree, A., & Feldstein, A. E. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2013.12.026 · Cited by 220
TAK1 Suppresses a NEMO-Dependent but NF-κB-Independent Pathway to Liver Cancer
Bettermann, K., Vucur, M., Haybaeck, J., Koppe, C., Janssen, J., Heymann, F., Weber, A., Weiskirchen, R., Liedtke, C., Gassler, N., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.03.021 · Cited by 217
Self-citationThe Caspase Inhibitor IDN-6556 Attenuates Hepatic Injury and Fibrosis in the Bile Duct Ligated Mouse
Canbay, A., Feldstein, A., Baskin-Bey, E., Bronk, S. F., & Gores, G. J. (2004) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.060129 · Cited by 215
Mathurin, P., Louvet, A., Duhamel, A., Nahon, P., Carbonell, N., Boursier, J., Anty, R., Diaz, E., Thabut, D., Moirand, R., et al. (2013) · JAMA · doi:10.1001/jama.2013.276300 · Cited by 210
Serum aminotransferase activity and mortality risk in a United States community
Lee, T. H., Kim, R. W., Benson, J. T., Therneau, T. M., & Melton, J. L. (2008) · Hepatology · doi:10.1002/hep.22090 · Cited by 208
Hepatic Immune Regulation and Its Involvement in Viral Hepatitis Infection
Knolle, P. A., & Thimme, R. (2014) · Gastroenterology · doi:10.1053/j.gastro.2013.12.036 · Cited by 206
A Perspective on Mammalian Caspases as Positive and Negative Regulators of Inflammation
Martin, S. J., Henry, C. M., & Cullen, S. P. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.04.026 · Cited by 205
Biliary repair and carcinogenesis are mediated by IL-33–dependent cholangiocyte proliferation
Li, J., Razumilava, N., Gores, G. J., Walters, S., Mizuochi, T., Mourya, R., Bessho, K., Wang, Y.-H., Glaser, S. S., Shivakumar, P., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci73742 · Cited by 202
Steroid Use in Acute Liver Failure
Karkhanis, J., Verna, E. C., Chang, M. S., Stravitz, T. R., Schilsky, M., Lee, W. M., & Brown, R. S. (2014) · Hepatology · doi:10.1002/hep.26678 · Cited by 199
Win, S., Than, T. A., Han, D., Petrovic, L. M., & Kaplowitz, N. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.276089 · Cited by 197
Self-citationA randomized trial of antioxidant therapy alone or with corticosteroids in acute alcoholic hepatitis
Stewart, S., Prince, M., Bassendine, M., Hudson, M., James, O., Jones, D., Record, C., & Day, C. P. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.03.027 · Cited by 196
The Bile Acid Glycochenodeoxycholate Induces TRAIL-Receptor 2/DR5 Expression and Apoptosis
Higuchi, H., Bronk, S. F., Takikawa, Y., Werneburg, N., Takimoto, R., El-Deiry, W., & Gores, G. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105300200 · Cited by 186
Joka, D., Wahl, K., Moeller, S., Schlue, J., Vaske, B., Bahr, M. J., Manns, M. P., Schulze-Osthoff, K., & Bantel, H. (2012) · Hepatology · doi:10.1002/hep.24734 · Cited by 184
Yanai, H., Matsuda, A., An, J., Koshiba, R., Nishio, J., Negishi, H., Ikushima, H., Onoe, T., Ohdan, H., Yoshida, N., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1320808110 · Cited by 184
Luedde, T., Assmus, U., Wüstefeld, T., Meyer zu Vilsendorf, A., Roskams, T., Schmidt-Supprian, M., Rajewsky, K., Brenner, D. A., Manns, M. P., Pasparakis, M., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200523493 · Cited by 178
Self-citationHepatic and serum levels of miR-122 after chronic HCV-induced fibrosis
Trebicka, J., Anadol, E., Elfimova, N., Strack, I., Roggendorf, M., Viazov, S., Wedemeyer, I., Drebber, U., Rockstroh, J., Sauerbruch, T., et al. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2012.10.015 · Cited by 172
Occurrence of cell death (apoptosis) during the involution of liver hyperplasia.
Columbano, A., Columbano, A., Coni, P., Faa, G., Liguori, C., Cruz, G. S., & Pani, P. (1985) · PubMed · Cited by 170
Dying a Thousand Deaths: Redundant Pathways From Different Organelles to Apoptosis and Necrosis
Lemasters, J. J. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.06.006 · Cited by 169
Diab, D. L., Yerian, L., Schauer, P., Kashyap, S. R., Lopez, R., Hazen, S. L., & Feldstein, A. E. (2008) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2008.07.016 · Cited by 168
Enhanced apoptosis relates to bile duct loss in primary biliary cirrhosis
Harada, K., Ozaki, S., Gershwin, M. E., & Nakanuma, Y. (1997) · Hepatology · doi:10.1002/hep.510260604 · Cited by 167
Vick, B., Weber, A., Urbanik, T., Maass, T., Teufel, A., Krammer, P. H., Opferman, J. T., Schuchmann, M., Galle, P. R., & Schulze‐Bergkamen, H. (2008) · Hepatology · doi:10.1002/hep.22664 · Cited by 165
Ratziu, V., Sheikh, M. Y., Sanyal, A. J., Lim, J. K., Conjeevaram, H., Chalasani, N., Abdelmalek, M., Bakken, A., Renou, C., Palmer, M., et al. (2012) · Hepatology · doi:10.1002/hep.24747 · Cited by 164
Tai, D., Lin, S., Sheen, I., Chu, C., Lin, D., & Liaw, Y. (2009) · Hepatology · doi:10.1002/hep.22878 · Cited by 164
Mei-Hsuan, L., Yang, H.-I., Lu, S.-N., Jen, C.-L., Yeh, S.-H., Liu, C.-J., Chen, P.-J., You, S.-L., Wang, L.-Y., Chen, W. J., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.29.1500 · Cited by 161
Amir, M., Zhao, E., Fontana, L., Rosenberg, H., Tanaka, K., Gao, G., & Czaja, M. J. (2013) · Cell Death & Differentiation · doi:10.1038/cdd.2013.21 · Cited by 160
Squires, R. H., Dhawan, A., Alonso, E., Narkewicz, M. R., Shneider, B. L., Rodriguez-Baez, N., Olio, D. D., Karpen, S., Bucuvalas, J., Lobritto, S., et al. (2013) · Hepatology · doi:10.1002/hep.26001 · Cited by 159
Anstee, Q. M., Concas, D., Kudo, H., Levene, A., Pollard, J., Charlton, P., Thomas, H. C., Thursz, M. R., & Goldin, R. D. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.03.016 · Cited by 158
Jiang, J. X., Mikami, K., Venugopal, S., Li, Y., & Török, N. J. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.03.024 · Cited by 158
Effectiveness of Hepatitis B Treatment in Clinical Practice
Scaglione, S., & Lok, A. S.-F. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.01.044 · Cited by 155
Pentoxifylline versus prednisolone for severe alcoholic hepatitis: A randomized controlled trial
De, B. K., Gangopadhyay, S., Dutta, D., Baksi, S. D., Pani, A., & Ghosh, P. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.1613 · Cited by 154
Hepatitis C virus infection and apoptosis
Fischer, R., Baumert, T., & Blum, H.-E. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i36.4865 · Cited by 150
Schwabe, R. F., Uchinami, H., Qian, T., Bennett, B. L., Lemasters, J. J., & Brenner, D. A. (2004) · The FASEB Journal · doi:10.1096/fj.03-0771fje · Cited by 150
Self-citationApoptosis in hepatitis C virus infection
Bantel, H., & Schulze‐Osthoff, K. (2003) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401119 · Cited by 149
Death receptor 5 mediated-apoptosis contributes to cholestatic liver disease
Takeda, K., Kojima, Y., Ikejima, K., Harada, K., Yamashina, S., Okumura, K., Aoyama, T., Frese, S., Ikeda, H., Haynes, N. M., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802702105 · Cited by 148
Feldstein, A. E., Alkhouri, N., Vito, R. D., Alisi, A., López, R., & Nobili, V. (2013) · The American Journal of Gastroenterology · doi:10.1038/ajg.2013.168 · Cited by 144
Cited by
Regulation of apoptosis in health and disease: the balancing act of BCL-2 family proteins
Singh, R., Letai, A., & Sarosiek, K. (2019) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-018-0089-8 · Cited by 2,111
Hepatic stellate cells as key target in liver fibrosis
Higashi, T., Friedman, S. L., & Hoshida, Y. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.05.007 · Cited by 1,485
Liver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives
Roehlen, N., Crouchet, E., & Baumert, T. F. (2020) · Cells · doi:10.3390/cells9040875 · Cited by 1,237
Liver fibrosis: Pathophysiology, pathogenetic targets and clinical issues
Parola, M., & Pinzani, M. (2019) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2018.09.002 · Cited by 1,160
Hepatic inflammation and fibrosis: Functional links and key pathways
Seki, E., & Schwabe, R. F. (2015) · Hepatology · doi:10.1002/hep.27332 · Cited by 972
Self-citation
Metadata
- Authors
- Luedde, T., Kaplowitz, N., & Schwabe, R. F.
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2014-10
- Volume
- 147
- Issue
- 4
- Pages
- 765-783.e4
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W2142225943
- Cited by
- 759
- References
- 259
- FWCI
- 18.86
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.